FLNT

SEC source: 0001437749-24-036844 · rdgdoc.xml · derivative · entry 1

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · The Schulke Inn Family Foundation Trust

Disclosed balance after: 259,156

Underlying: Common Stock · 259,156 shares

Expires not disclosed

F1 · kind: On December 4, 2024, the reporting person filed a Form 4 which inadvertently reported the transaction code as "P." The transaction code should have been reported as "A" for a grant, award or other acquisition pursuant to Rule 16b-3(d).

F2 · derivative.exercise_date: The Pre-Funded Warrants will be exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants.

F3 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

F4 · ownership.nature: The Reporting Person is the Co-Trustee of The Schulke Inn Family Foundation Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust.

SEC source: 0001437749-24-036843 · rdgdoc.xml · derivative · entry 1

Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,596

Underlying: Common Stock · 21,596 shares

Expires not disclosed

F1 · kind: On December 4, 2024, the reporting person filed a Form 4 which inadvertently reported the transaction code as "P." The transaction code should have been reported as "A" for a grant, award or other acquisition pursuant to Rule 16b-3(d).

F2 · derivative.exercise_date: The Pre-Funded will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants.

F3 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

SEC source: 0001437749-24-037603 · rdgdoc.xml · nonDerivative · entry 1

Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 329,063

F1 · price: The sales price reflects a weighted average of multiple prices ranging from $2.56 to $2.74. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer, or security holder of the Issuer upon request.

SEC source: 0001437749-24-028986 · rdgdoc.xml · derivative · entry 2

Perfit Ryan MacNab · CIK 0001735369 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2034-09-09

F2 · shares: The options ("Options") were issued pursuant to the Plan and vest as follows: (i) one-half of the Options vest when the average closing price of the Issuer's common stock is equal to three times the exercise price of the Option for a period of ten consecutive trading days and (ii) the balance, or one-half of the Options vest when the average closing price of the Issuer's common stock is equal to five times the exercise price of the Option for a period of ten consecutive trading days.

F2 · derivative.exercise_date: The options ("Options") were issued pursuant to the Plan and vest as follows: (i) one-half of the Options vest when the average closing price of the Issuer's common stock is equal to three times the exercise price of the Option for a period of ten consecutive trading days and (ii) the balance, or one-half of the Options vest when the average closing price of the Issuer's common stock is equal to five times the exercise price of the Option for a period of ten consecutive trading days.

SEC source: 0001437749-24-028986 · rdgdoc.xml · nonDerivative · entry 1

Perfit Ryan MacNab · CIK 0001735369 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,596

F1 · shares: The restricted stock units were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan (the "Plan") and vest in three equal annual installments with the first tranche vesting on September 1, 2025.

SEC source: 0001437749-26-020481 · rdgdoc.xml · nonDerivative · entry 1

Perfit Ryan MacNab · CIK 0001735369 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,600

F1 · shares: The restricted stock units ("RSUs") were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan (the "Plan") and vest in three equal annual installments with the first tranche vesting on September 1, 2025.

F2 · balance_after: On September 11, 2024, the Reporting Person filed a Form 4 which inadvertently reported, that following his acquisition of 25,000 RSUs, the Reporting Person owned 70,596 shares of common stock which amount did not reflect the Issuer's 1-for-6 reverse stock split effectuated on April 11, 2024. As reported in this amendment, following the acquisition of 25,000 RSUs, the Reporting Person owned 32,600 shares of common stock

SEC source: 0001437749-24-027460 · rdgdoc.xml · derivative · entry 1

FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner

Frost Gamma Investments Trust · CIK 0001380896 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Frost Gamma Investments Trust

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2029-04-02

F1 · derivative.exercise_price: The Convertible Subordinated Promissory Note (the "Note") accrues interest at 13% per annum and is convertible into shares of the Issuer's common stock at the Conversion Price. "Conversion Price" means an amount equal to the lesser of (i) $3.01, subject to adjustment pursuant to the terms of the Note and (ii) the greater of (A) the consolidated closing bid price of the Issuer's common stock as reported on The Nasdaq Capital Market or such other principal market or exchange on which the common stock is then traded (the "Principal Market") on the applicable conversion date or, if such date is not a Trading Day, then on the Trading Date that is immediately prior to the applicable conversion date and (B) $1.00, subject to adjustment pursuant to the terms of the Note; provided, however, that the applicable Conversion Price shall in no event be lower than the price established by clause (ii) (continued)

F2 · derivative.exercise_price: above unless and until the Issuer obtains stockholder approval of the transactions contemplated by the Note, including the conversion features and pricing thereof, in accordance with the applicable rules of the Principal Market (or any other applicable national securities exchange) (the "Stockholder Approval"). Notwithstanding the foregoing, the Note is subject to additional limits on conversion until the Stockholder Approval is obtained, including an aggregate limit on the number of shares that may be issued upon conversion of all notes issued to investors on August 19, 2024, including the Note (collectively, the "August Notes"), to 19.99% of the Issuer's outstanding shares of common stock and provisions to prevent a change of control as defined in the rules of the Nasdaq Stock Market. (continued)

F3 · derivative.exercise_price: The Issuer has agreed to use its reasonable efforts to secure the Stockholder Approval, including providing a recommendation FOR approval by the Issuer's board of directors. Holders of the August Notes will be permitted to vote on the Stockholder Approval, but may not vote any shares obtained from conversion of the August Notes prior to such vote. "Trading Day" means any day during which the Principal Market is open for trading.

F4 · reported_value: The amount reflected here is in dollars.

F1 · underlyingValue: The Convertible Subordinated Promissory Note (the "Note") accrues interest at 13% per annum and is convertible into shares of the Issuer's common stock at the Conversion Price. "Conversion Price" means an amount equal to the lesser of (i) $3.01, subject to adjustment pursuant to the terms of the Note and (ii) the greater of (A) the consolidated closing bid price of the Issuer's common stock as reported on The Nasdaq Capital Market or such other principal market or exchange on which the common stock is then traded (the "Principal Market") on the applicable conversion date or, if such date is not a Trading Day, then on the Trading Date that is immediately prior to the applicable conversion date and (B) $1.00, subject to adjustment pursuant to the terms of the Note; provided, however, that the applicable Conversion Price shall in no event be lower than the price established by clause (ii) (continued)

F2 · underlyingValue: above unless and until the Issuer obtains stockholder approval of the transactions contemplated by the Note, including the conversion features and pricing thereof, in accordance with the applicable rules of the Principal Market (or any other applicable national securities exchange) (the "Stockholder Approval"). Notwithstanding the foregoing, the Note is subject to additional limits on conversion until the Stockholder Approval is obtained, including an aggregate limit on the number of shares that may be issued upon conversion of all notes issued to investors on August 19, 2024, including the Note (collectively, the "August Notes"), to 19.99% of the Issuer's outstanding shares of common stock and provisions to prevent a change of control as defined in the rules of the Nasdaq Stock Market. (continued)

F3 · underlyingValue: The Issuer has agreed to use its reasonable efforts to secure the Stockholder Approval, including providing a recommendation FOR approval by the Issuer's board of directors. Holders of the August Notes will be permitted to vote on the Stockholder Approval, but may not vote any shares obtained from conversion of the August Notes prior to such vote. "Trading Day" means any day during which the Principal Market is open for trading.

F5 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001437749-24-027445 · rdgdoc.xml · derivative · entry 1

Perfit Ryan MacNab · CIK 0001735369 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2029-04-02

F1 · derivative.exercise_price: The Convertible Subordinated Promissory Note (the "Note") accrues interest at 13% per annum and is convertible into shares of the Issuer's common stock at the Conversion Price. "Conversion Price" means an amount equal to the lesser of (i) $3.01, subject to adjustment pursuant to the terms of the Note and (ii) the greater of (A) the consolidated closing bid price of the Issuer's common stock as reported on The Nasdaq Capital Market or such other principal market or exchange on which the common stock is then traded (the "Principal Market") on the applicable conversion date or, if such date is not a Trading Day, then on the Trading Date that is immediately prior to the applicable conversion date and (B) $1.00, subject to adjustment pursuant to the terms of the Note; provided, however, that the applicable Conversion Price shall in no event be lower than the price established by clause (ii) (continued)

F2 · derivative.exercise_price: above unless and until the Issuer obtains stockholder approval of the transactions contemplated by the Note, including the conversion features and pricing thereof, in accordance with the applicable rules of the Principal Market (or any other applicable national securities exchange) (the "Stockholder Approval"). Notwithstanding the foregoing, the Note is subject to additional limits on conversion until the Stockholder Approval is obtained, including an aggregate limit on the number of shares that may be issued upon conversion of all notes issued to investors on August 19, 2024, including the Note (collectively, the "August Notes"), to 19.99% of the Issuer's outstanding shares of common stock and provisions to prevent a change of control as defined in the rules of the Nasdaq Stock Market. (continued)

F3 · derivative.exercise_price: The Issuer has agreed to use its reasonable efforts to secure the Stockholder Approval, including providing a recommendation FOR approval by the Issuer's board of directors. Holders of the August Notes will be permitted to vote on the Stockholder Approval, but may not vote any shares obtained from conversion of the August Notes prior to such vote. "Trading Day" means any day during which the Principal Market is open for trading.

F1 · underlyingValue: The Convertible Subordinated Promissory Note (the "Note") accrues interest at 13% per annum and is convertible into shares of the Issuer's common stock at the Conversion Price. "Conversion Price" means an amount equal to the lesser of (i) $3.01, subject to adjustment pursuant to the terms of the Note and (ii) the greater of (A) the consolidated closing bid price of the Issuer's common stock as reported on The Nasdaq Capital Market or such other principal market or exchange on which the common stock is then traded (the "Principal Market") on the applicable conversion date or, if such date is not a Trading Day, then on the Trading Date that is immediately prior to the applicable conversion date and (B) $1.00, subject to adjustment pursuant to the terms of the Note; provided, however, that the applicable Conversion Price shall in no event be lower than the price established by clause (ii) (continued)

F2 · underlyingValue: above unless and until the Issuer obtains stockholder approval of the transactions contemplated by the Note, including the conversion features and pricing thereof, in accordance with the applicable rules of the Principal Market (or any other applicable national securities exchange) (the "Stockholder Approval"). Notwithstanding the foregoing, the Note is subject to additional limits on conversion until the Stockholder Approval is obtained, including an aggregate limit on the number of shares that may be issued upon conversion of all notes issued to investors on August 19, 2024, including the Note (collectively, the "August Notes"), to 19.99% of the Issuer's outstanding shares of common stock and provisions to prevent a change of control as defined in the rules of the Nasdaq Stock Market. (continued)

F3 · underlyingValue: The Issuer has agreed to use its reasonable efforts to secure the Stockholder Approval, including providing a recommendation FOR approval by the Issuer's board of directors. Holders of the August Notes will be permitted to vote on the Stockholder Approval, but may not vote any shares obtained from conversion of the August Notes prior to such vote. "Trading Day" means any day during which the Principal Market is open for trading.

SEC source: 0001437749-24-027443 · rdgdoc.xml · derivative · entry 1

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2029-04-02

F1 · derivative.exercise_price: The Convertible Subordinated Promissory Note (the "Note") accrues interest at 13% per annum and is convertible into shares of the Issuer's common stock at the Conversion Price. "Conversion Price" means an amount equal to the lesser of (i) $3.01, subject to adjustment pursuant to the terms of the Note and (ii) the greater of (A) the consolidated closing bid price of the Issuer's common stock as reported on The Nasdaq Capital Market or such other principal market or exchange on which the common stock is then traded (the "Principal Market") on the applicable conversion date or, if such date is not a Trading Day, then on the Trading Date that is immediately prior to the applicable conversion date and (B) $1.00, subject to adjustment pursuant to the terms of the Note; provided, however, that the applicable Conversion Price shall in no event be lower than the price established by clause (ii) (continued)

F2 · derivative.exercise_price: above unless and until the Issuer obtains stockholder approval of the transactions contemplated by the Note, including the conversion features and pricing thereof, in accordance with the applicable rules of the Principal Market (or any other applicable national securities exchange) (the "Stockholder Approval"). Notwithstanding the foregoing, the Note is subject to additional limits on conversion until the Stockholder Approval is obtained, including an aggregate limit on the number of shares that may be issued upon conversion of all notes issued to investors on August 19, 2024, including the Note (collectively, the "August Notes"), to 19.99% of the Issuer's outstanding shares of common stock and provisions to prevent a change of control as defined in the rules of the Nasdaq Stock Market. (continued)

F3 · derivative.exercise_price: The Issuer has agreed to use its reasonable efforts to secure the Stockholder Approval, including providing a recommendation FOR approval by the Issuer's board of directors. Holders of the August Notes will be permitted to vote on the Stockholder Approval, but may not vote any shares obtained from conversion of the August Notes prior to such vote. "Trading Day" means any day during which the Principal Market is open for trading.

F1 · underlyingValue: The Convertible Subordinated Promissory Note (the "Note") accrues interest at 13% per annum and is convertible into shares of the Issuer's common stock at the Conversion Price. "Conversion Price" means an amount equal to the lesser of (i) $3.01, subject to adjustment pursuant to the terms of the Note and (ii) the greater of (A) the consolidated closing bid price of the Issuer's common stock as reported on The Nasdaq Capital Market or such other principal market or exchange on which the common stock is then traded (the "Principal Market") on the applicable conversion date or, if such date is not a Trading Day, then on the Trading Date that is immediately prior to the applicable conversion date and (B) $1.00, subject to adjustment pursuant to the terms of the Note; provided, however, that the applicable Conversion Price shall in no event be lower than the price established by clause (ii) (continued)

F2 · underlyingValue: above unless and until the Issuer obtains stockholder approval of the transactions contemplated by the Note, including the conversion features and pricing thereof, in accordance with the applicable rules of the Principal Market (or any other applicable national securities exchange) (the "Stockholder Approval"). Notwithstanding the foregoing, the Note is subject to additional limits on conversion until the Stockholder Approval is obtained, including an aggregate limit on the number of shares that may be issued upon conversion of all notes issued to investors on August 19, 2024, including the Note (collectively, the "August Notes"), to 19.99% of the Issuer's outstanding shares of common stock and provisions to prevent a change of control as defined in the rules of the Nasdaq Stock Market. (continued)

F3 · underlyingValue: The Issuer has agreed to use its reasonable efforts to secure the Stockholder Approval, including providing a recommendation FOR approval by the Issuer's board of directors. Holders of the August Notes will be permitted to vote on the Stockholder Approval, but may not vote any shares obtained from conversion of the August Notes prior to such vote. "Trading Day" means any day during which the Principal Market is open for trading.

SEC source: 0001437749-24-027441 · rdgdoc.xml · derivative · entry 1

Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2029-04-02

F1 · derivative.exercise_price: The Convertible Subordinated Promissory Note (the "Note") accrues interest at 13% per annum and is convertible into shares of the Issuer's common stock at the Conversion Price. "Conversion Price" means an amount equal to the lesser of (i) $3.01, subject to adjustment pursuant to the terms of the Note and (ii) the greater of (A) the consolidated closing bid price of the Issuer's common stock as reported on The Nasdaq Capital Market or such other principal market or exchange on which the common stock is then traded (the "Principal Market") on the applicable conversion date or, if such date is not a Trading Day, then on the Trading Date that is immediately prior to the applicable conversion date and (B) $1.00, subject to adjustment pursuant to the terms of the Note; provided, however, that the applicable Conversion Price shall in no event be lower than the price established by clause (ii) (continued)

F2 · derivative.exercise_price: above unless and until the Issuer obtains stockholder approval of the transactions contemplated by the Note, including the conversion features and pricing thereof, in accordance with the applicable rules of the Principal Market (or any other applicable national securities exchange) (the "Stockholder Approval"). Notwithstanding the foregoing, the Note is subject to additional limits on conversion until the Stockholder Approval is obtained, including an aggregate limit on the number of shares that may be issued upon conversion of all notes issued to investors on August 19, 2024, including the Note (collectively, the "August Notes"), to 19.99% of the Issuer's outstanding shares of common stock and provisions to prevent a change of control as defined in the rules of the Nasdaq Stock Market. (continued)

F3 · derivative.exercise_price: The Issuer has agreed to use its reasonable efforts to secure the Stockholder Approval, including providing a recommendation FOR approval by the Issuer's board of directors. Holders of the August Notes will be permitted to vote on the Stockholder Approval, but may not vote any shares obtained from conversion of the August Notes prior to such vote. "Trading Day" means any day during which the Principal Market is open for trading.

F1 · underlyingValue: The Convertible Subordinated Promissory Note (the "Note") accrues interest at 13% per annum and is convertible into shares of the Issuer's common stock at the Conversion Price. "Conversion Price" means an amount equal to the lesser of (i) $3.01, subject to adjustment pursuant to the terms of the Note and (ii) the greater of (A) the consolidated closing bid price of the Issuer's common stock as reported on The Nasdaq Capital Market or such other principal market or exchange on which the common stock is then traded (the "Principal Market") on the applicable conversion date or, if such date is not a Trading Day, then on the Trading Date that is immediately prior to the applicable conversion date and (B) $1.00, subject to adjustment pursuant to the terms of the Note; provided, however, that the applicable Conversion Price shall in no event be lower than the price established by clause (ii) (continued)

F2 · underlyingValue: above unless and until the Issuer obtains stockholder approval of the transactions contemplated by the Note, including the conversion features and pricing thereof, in accordance with the applicable rules of the Principal Market (or any other applicable national securities exchange) (the "Stockholder Approval"). Notwithstanding the foregoing, the Note is subject to additional limits on conversion until the Stockholder Approval is obtained, including an aggregate limit on the number of shares that may be issued upon conversion of all notes issued to investors on August 19, 2024, including the Note (collectively, the "August Notes"), to 19.99% of the Issuer's outstanding shares of common stock and provisions to prevent a change of control as defined in the rules of the Nasdaq Stock Market. (continued)

F3 · underlyingValue: The Issuer has agreed to use its reasonable efforts to secure the Stockholder Approval, including providing a recommendation FOR approval by the Issuer's board of directors. Holders of the August Notes will be permitted to vote on the Stockholder Approval, but may not vote any shares obtained from conversion of the August Notes prior to such vote. "Trading Day" means any day during which the Principal Market is open for trading.

SEC source: 0001437749-24-027439 · rdgdoc.xml · derivative · entry 1

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2029-04-02

F1 · derivative.exercise_price: The Convertible Subordinated Promissory Note (the "Note") accrues interest at 13% per annum and is convertible into shares of the Issuer's common stock at the Conversion Price. "Conversion Price" means an amount equal to the lesser of (i) $3.01, subject to adjustment pursuant to the terms of the Note and (ii) the greater of (A) the consolidated closing bid price of the Issuer's common stock as reported on The Nasdaq Capital Market or such other principal market or exchange on which the common stock is then traded (the "Principal Market") on the applicable conversion date or, if such date is not a Trading Day, then on the Trading Date that is immediately prior to the applicable conversion date and (B) $1.00, subject to adjustment pursuant to the terms of the Note; provided, however, that the applicable Conversion Price shall in no event be lower than the price established by clause (ii) (continued)

F2 · derivative.exercise_price: above unless and until the Issuer obtains stockholder approval of the transactions contemplated by the Note, including the conversion features and pricing thereof, in accordance with the applicable rules of the Principal Market (or any other applicable national securities exchange) (the "Stockholder Approval"). Notwithstanding the foregoing, the Note is subject to additional limits on conversion until the Stockholder Approval is obtained, including an aggregate limit on the number of shares that may be issued upon conversion of all notes issued to investors on August 19, 2024, including the Note (collectively, the "August Notes"), to 19.99% of the Issuer's outstanding shares of common stock and provisions to prevent a change of control as defined in the rules of the Nasdaq Stock Market. (continued)

F3 · derivative.exercise_price: The Issuer has agreed to use its reasonable efforts to secure the Stockholder Approval, including providing a recommendation FOR approval by the Issuer's board of directors. Holders of the August Notes will be permitted to vote on the Stockholder Approval, but may not vote any shares obtained from conversion of the August Notes prior to such vote. "Trading Day" means any day during which the Principal Market is open for trading.

F1 · derivative.underlying_shares: The Convertible Subordinated Promissory Note (the "Note") accrues interest at 13% per annum and is convertible into shares of the Issuer's common stock at the Conversion Price. "Conversion Price" means an amount equal to the lesser of (i) $3.01, subject to adjustment pursuant to the terms of the Note and (ii) the greater of (A) the consolidated closing bid price of the Issuer's common stock as reported on The Nasdaq Capital Market or such other principal market or exchange on which the common stock is then traded (the "Principal Market") on the applicable conversion date or, if such date is not a Trading Day, then on the Trading Date that is immediately prior to the applicable conversion date and (B) $1.00, subject to adjustment pursuant to the terms of the Note; provided, however, that the applicable Conversion Price shall in no event be lower than the price established by clause (ii) (continued)

F2 · derivative.underlying_shares: above unless and until the Issuer obtains stockholder approval of the transactions contemplated by the Note, including the conversion features and pricing thereof, in accordance with the applicable rules of the Principal Market (or any other applicable national securities exchange) (the "Stockholder Approval"). Notwithstanding the foregoing, the Note is subject to additional limits on conversion until the Stockholder Approval is obtained, including an aggregate limit on the number of shares that may be issued upon conversion of all notes issued to investors on August 19, 2024, including the Note (collectively, the "August Notes"), to 19.99% of the Issuer's outstanding shares of common stock and provisions to prevent a change of control as defined in the rules of the Nasdaq Stock Market. (continued)

F3 · derivative.underlying_shares: The Issuer has agreed to use its reasonable efforts to secure the Stockholder Approval, including providing a recommendation FOR approval by the Issuer's board of directors. Holders of the August Notes will be permitted to vote on the Stockholder Approval, but may not vote any shares obtained from conversion of the August Notes prior to such vote. "Trading Day" means any day during which the Principal Market is open for trading.

SEC source: 0001437749-24-022941 · rdgdoc.xml · derivative · entry 2

Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,551 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The Pre-Funded Warrants became immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants, which approval was obtained on July 2, 2024. The binding agreement for the transaction was entered into on May 13, 2024.

F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

SEC source: 0001437749-24-022941 · rdgdoc.xml · nonDerivative · entry 1

Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,313

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-24-022933 · rdgdoc.xml · derivative · entry 6

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Conlin Family Foundation Trust

Disclosed balance after: 0

Underlying: Common Stock · 73,877 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The Pre-Funded Warrants became immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants, which approval was obtained on July 2, 2024. The binding agreements for the transactions were entered into on May 13, 2024.

F5 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

F1 · ownership.nature: The Reporting Person is the Co-Trustee of the Conlin Family Foundation Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust.

SEC source: 0001437749-24-022933 · rdgdoc.xml · derivative · entry 5

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 487,589 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The Pre-Funded Warrants became immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants, which approval was obtained on July 2, 2024. The binding agreements for the transactions were entered into on May 13, 2024.

F5 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

SEC source: 0001437749-24-022933 · rdgdoc.xml · nonDerivative · entry 2

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Conlin Family Foundation Trust

Disclosed balance after: 125,039

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: The Reporting Person is the Co-Trustee of the Conlin Family Foundation Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust.

SEC source: 0001437749-24-022933 · rdgdoc.xml · nonDerivative · entry 1

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,601,164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-24-022544 · rdgdoc.xml · derivative · entry 6

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,743,499 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The Pre-Funded Warrants became immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants, which approval was obtained on July 2, 2024. The binding agreement for the transaction was entered into on May 13, 2024.

F6 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

SEC source: 0001437749-24-022544 · rdgdoc.xml · nonDerivative · entry 1

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,941,164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-24-022293 · rdgdoc.xml · derivative · entry 3

FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner

Frost Gamma Investments Trust · CIK 0001380896 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Frost Gamma Investments Trust

Disclosed balance after: 0

Underlying: Common Stock · 591,017 shares

Expires not disclosed

F2 · derivative.exercise_date: The Pre-Funded Warrants became immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants, which approval was obtained on July 2, 2024. The binding agreement for the transaction was entered into on May 13, 2024.

F3 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001437749-24-022293 · rdgdoc.xml · nonDerivative · entry 1

FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner

Frost Gamma Investments Trust · CIK 0001380896 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Frost Gamma Investments Trust

Disclosed balance after: 3,730,164

F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001437749-24-022127 · rdgdoc.xml · nonDerivative · entry 3

Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,762

F2 · shares: On April 11, 2024, the Issuer effected a 6-for-1 reverse stock split. The holding reported here reflects such reverse stock split.

F4 · shares: On June 28, 2024, the Reporting Person was issued 76,584 restricted stock units ("RSUs") pursuant to the Issuer's long-term incentive plan. The RSUs vest in three equal annual installments with the first installment vesting on April 1, 2025.

F2 · balance_after: On April 11, 2024, the Issuer effected a 6-for-1 reverse stock split. The holding reported here reflects such reverse stock split.

SEC source: 0001437749-26-020482 · rdgdoc.xml · nonDerivative · entry 1

Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,767

F1 · balance_after: On July 3, 2024, the Reporting Person filed a Form 4 which inadvertently reported, that following his activity, the Reporting Person owned a total of 319,762 shares of common stock which amount did not accurately reflect the total impact for Issuer's 1-for-6 reverse stock split effectuated on April 11, 2024. As reported in this amendment, following the activity, the Reporting Person owned 319,767 shares of common stock.

SEC source: 0001437749-24-020651 · rdgdoc.xml · nonDerivative · entry 5

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · The Schulke Inn Family Family Foundation Trust in which the Reporting Person serves as a Co-Trustee

Disclosed balance after: 103,027

F5 · price: The price listed in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.41 to $3.4155, inclusive. The Reporting Person undertakes to provide Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F1 · balance_after: On April 11, 2024, the Issuer effected a 6-for-1 reverse stock split (the "Reverse Stock Split"). The holding report here reflects such Reverse Stock Split.

F6 · ownership.nature: The reporting person is the Co-Trustee of The Schulke Inn Family Foundation Trust.

SEC source: 0001437749-24-021881 · rdgdoc.xml · nonDerivative · entry 1

SHATTUCK KOHN BARBARA · CIK 0001013803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,779

F1 · shares: On April 11, 2024, the Issuer effected a 6-for-1 reverse stock split (the "Reverse Stock Split"). The holding reported here reflects the Reverse Stock Split.

F2 · shares: On June 5, 2024, the Reporting Person received a grant of 21,429 restricted stock units ("RSUs") under the Issuer's 2022 Omnibus Equity Incentive Plan. These RSUs will vest in three equal annual installments, beginning on June 1, 2025.

SEC source: 0001437749-24-021883 · rdgdoc.xml · nonDerivative · entry 1

Mathis Donald H · CIK 0001661543 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,083

F1 · shares: On April 11, 2024, the Issuer effected a 6-for-1 reverse stock split (the "Reverse Stock Split"). The holding reported here reflects the Reverse Stock Split.

F2 · shares: On June 5, 2024, the Reporting Person received a grant of 21,429 restricted stock units ("RSUs") under the Issuer's 2022 Omnibus Equity Incentive Plan. These RSUs will vest in three equal annual installments, beginning on June 1, 2025.

SEC source: 0001437749-24-021888 · rdgdoc.xml · nonDerivative · entry 1

PFENNIGER RICHARD C JR · CIK 0001200796 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,659

F1 · shares: On April 11, 2024, the Issuer effected a 6-for-1 reverse stock split (the "Reverse Stock Split"). The holding reported here reflects the Reverse Stock Split.

F2 · shares: On June 5, 2024, the Reporting Person received a grant of 21,429 restricted stock units ("RSUs") under the Issuer's 2022 Omnibus Equity Incentive Plan. These RSUs will vest in three equal annual installments, beginning on June 1, 2025.

SEC source: 0001437749-24-021886 · rdgdoc.xml · nonDerivative · entry 1

Graff David Allen · CIK 0001950328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,659

F1 · shares: On April 11, 2024, the Issuer effected a 6-for-1 reverse stock split (the "Reverse Stock Split"). The holding reported here reflects the Reverse Stock Split.

F2 · shares: On June 5, 2024, the Reporting Person received a grant of 21,429 restricted stock units ("RSUs") under the Issuer's 2022 Omnibus Equity Incentive Plan. These RSUs will vest in three equal annual installments, beginning on June 1, 2025.

SEC source: 0001437749-26-021160 · rdgdoc.xml · nonDerivative · entry 1

Mathis Donald H · CIK 0001661543 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,088

F1 · balance_after: On April 11, 2024, the Issuer effected a 6-for-1 reverse stock split (the "Reverse Stock Split"). The holding reported here reflects the Reverse Stock Split.

F2 · balance_after: On June 5, 2024, the Reporting Person received a grant of 21,429 restricted stock units ("RSUs") under the Issuer's 2022 Omnibus Equity Incentive Plan. These RSUs will vest in three equal annual installments, beginning on June 1, 2025.

F3 · balance_after: On July 2, 2024, the Reporting Person filed a Form 4 which inadvertently reported, that following his activity, the Reporting Person owned a total of 86,083 shares of common stock which amount did not accurately reflect the total impact for Issuer's 1-for-6 reverse stock split effectuated on April 11, 2024. As reported in this amendment, following the activity, the Reporting Person owned 86,088 shares of common stock.

SEC source: 0001437749-26-021161 · rdgdoc.xml · nonDerivative · entry 1

SHATTUCK KOHN BARBARA · CIK 0001013803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,782

F1 · balance_after: On June 5, 2024, the Reporting Person filed a Form 4 which inadvertently reported, that following her activity, the Reporting Person owned a total of 70,779 shares of common stock which amount did not accurately reflect the total impact for Issuer's 1-for-6 reverse stock split effectuated on April 11, 2024. As reported in this amendment, following the activity, the Reporting Person owned 70,782 shares of common stock.

SEC source: 0001437749-26-021163 · rdgdoc.xml · nonDerivative · entry 1

PFENNIGER RICHARD C JR · CIK 0001200796 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,660

F1 · balance_after: On June 5, 2024, the Reporting Person filed a Form 4 which inadvertently reported, that following his activity, the Reporting Person owned a total of 50,659 shares of common stock which amount did not accurately reflect the total impact for Issuer's 1-for-6 reverse stock split effectuated on April 11, 2024. As reported in this amendment, following the activity, the Reporting Person owned 50,660 shares of common stock.

SEC source: 0001437749-26-021162 · rdgdoc.xml · nonDerivative · entry 1

Graff David Allen · CIK 0001950328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,660

F1 · balance_after: On June 5, 2024, the Reporting Person filed a Form 4 which inadvertently reported, that following his activity, the Reporting Person owned a total of 50,659 shares of common stock which amount did not accurately reflect the total impact for Issuer's 1-for-6 reverse stock split effectuated on April 11, 2024. As reported in this amendment, following the activity, the Reporting Person owned 50,660 shares of common stock.

SEC source: 0001437749-24-017188 · rdgdoc.xml · derivative · entry 3

FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner

Frost Gamma Investments Trust · CIK 0001380896 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Frost Gamma Investments Trust

Disclosed balance after: 591,017

Underlying: Common Stock · 591,017 shares

Expires not disclosed

F2 · derivative.exercise_date: The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. The binding agreement for the transaction was entered into on May 13, 2024.

F3 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

F4 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

SEC source: 0001437749-24-017193 · rdgdoc.xml · derivative · entry 6

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Conlin Family Foundation Trust

Disclosed balance after: 73,877

Underlying: Common Stock · 73,877 shares

Expires not disclosed

F5 · derivative.exercise_date: The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. The binding agreements for the transactions were entered into on May 13, 2024.

F6 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

F2 · ownership.nature: The Reporting Person is a Member of RSMC Partners, LLC.

SEC source: 0001437749-24-017193 · rdgdoc.xml · derivative · entry 5

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 487,589

Underlying: Common Stock · 487,589 shares

Expires not disclosed

F5 · derivative.exercise_date: The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. The binding agreements for the transactions were entered into on May 13, 2024.

F6 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

SEC source: 0001437749-24-017366 · rdgdoc.xml · derivative · entry 1

Patrick Donald Huntley · CIK 0001735387 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,551

Underlying: Common Stock · 29,551 shares

Expires not disclosed

F1 · derivative.exercise_date: The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. The binding agreement for the transaction was entered into on May 13, 2024.

F2 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

SEC source: 0001437749-24-017294 · rdgdoc.xml · derivative · entry 6

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,743,499

Underlying: Common Stock · 1,743,499 shares

Expires not disclosed

F6 · derivative.exercise_date: The Pre-Funded Warrants will be immediately exercisable after stockholder approval of the offering of the Issuer's Pre-Funded Warrants. The binding agreement for the transaction was entered into on May 13, 2024.

F7 · derivative.expiration_date: The Pre-Funded Warrants will terminate when exercised in full.

SEC source: 0001437749-24-007901 · rdgdoc.xml · nonDerivative · entry 6

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · The Schulke Inn Family Family Foundation Trust in which the Reporting Peron serves as a Co-Trustee

Disclosed balance after: 600,159

F5 · price: The price listed in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.5200 to $0.5300, inclusive. The Reporting Person undertakes to provide Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001437749-25-012470 · rdgdoc.xml · nonDerivative · entry 1

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Conlin Family Foundation Trust

Disclosed balance after: 306,970

F1 · date: On March 14, 2024, the Reporting Person filed a Form 4 that erroneously reported the transaction date as being March 14, 2023, rather than March 14, 2024. The Reporting Person is amending the Form 4 to report the correct date of the transaction.

F2 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.5370 to $0.5500, inclusive. The Reporting Person undertakes to provide to Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range specified in this footnote.

F3 · ownership.nature: The Reporting Person is the Co-Trustee of the Conlin Family Foundation Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust.

SEC source: 0001437749-24-007901 · rdgdoc.xml · nonDerivative · entry 5

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · The Schulke Inn Family Family Foundation Trust in which the Reporting Peron serves as a Co-Trustee

Disclosed balance after: 579,159

F4 · price: The price listed in Column 4 is a weighted average price. The Reporting Person undertakes to provide Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001437749-24-007510 · rdgdoc.xml · nonDerivative · entry 5

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · The Schulke Inn Family Family Foundation Trust in which the Reporting Peron serves as a Co-Trustee

Disclosed balance after: 569,159

F4 · price: The price listed in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.5784 to $0.6000, inclusive. The Reporting Person undertakes to provide Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001437749-25-012468 · rdgdoc.xml · nonDerivative · entry 2

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Conlin Family Foundation Trust

Disclosed balance after: 281,970

F4 · date: On March 12, 2024, the Reporting Person filed a Form 4 that erroneously reported the transaction date as being March 12, 2023, rather than March 12, 2024. The Reporting Person is amending the Form 4 to report the correct date of the transaction.

F2 · price: The price reported in column 4 is a weighted average price. The Reporting Person undertakes to provide to Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range specified in this footnote.

F3 · ownership.nature: The Reporting Person is the Co-Trustee of the Conlin Family Foundation Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust.

SEC source: 0001437749-24-007512 · rdgdoc.xml · nonDerivative · entry 2

Perfit Ryan MacNab · CIK 0001735369 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,596

SEC source: 0001437749-25-012468 · rdgdoc.xml · nonDerivative · entry 1

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Conlin Family Foundation Trust

Disclosed balance after: 271,970

F1 · date: On March 12, 2024, the Reporting Person filed a Form 4 that erroneously reported the transaction date as being March 11, 2023, rather than March 11, 2024. The Reporting Person is amending the Form 4 to report the correct date of the transaction.

F2 · price: The price reported in column 4 is a weighted average price. The Reporting Person undertakes to provide to Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range specified in this footnote.

F3 · ownership.nature: The Reporting Person is the Co-Trustee of the Conlin Family Foundation Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust.

SEC source: 0001437749-24-007363 · rdgdoc.xml · nonDerivative · entry 5

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · The Schulke Inn Family Family Foundation Trust in which the Reporting Peron serves as a Co-Trustee

Disclosed balance after: 549,159

F4 · price: The price listed in Column 4 is a weighted average price. The Reporting Person undertakes to provide Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001437749-24-007512 · rdgdoc.xml · nonDerivative · entry 1

Perfit Ryan MacNab · CIK 0001735369 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,596

SEC source: 0001437749-25-012466 · rdgdoc.xml · nonDerivative · entry 1

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Conlin Family Foundation Trust

Disclosed balance after: 261,970

F1 · date: On March 11, 2024, the Reporting Person filed a Form 4 that erroneously reported the transaction date as March 8, 2023, rather than March 8, 2024. The Reporting Person is amending the Form 4 to report the correct date of the transaction.

F2 · price: The price reported in column 4 is a weighted average price. The Reporting Person undertakes to provide to Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range specified in this footnote.

F3 · ownership.nature: The Reporting Person is the Co-Trustee of the Conlin Family Foundation Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust.

SEC source: 0001437749-24-007018 · rdgdoc.xml · nonDerivative · entry 5

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · The Schulke Inn Family Family Foundation Trust in which the Reporting Peron serves as a Co-Trustee

Disclosed balance after: 539,159

F4 · price: The price listed in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5850 to $0.5906, inclusive. The Reporting Person undertakes to provide Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001437749-25-012379 · rdgdoc.xml · nonDerivative · entry 2

Conlin Matthew · CIK 0001660879 · Director · Chief Customer Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Conlin Family Foundation Trust

Disclosed balance after: 251,970

F3 · date: On March 7, 2024, the Reporting Person filed a Form 4 that erroneously reported the transaction date as being March 7, 2023 rather than March 7, 2024. The Reporting Person is amending the Form 4 to correct the date of the transaction.

F4 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5891 to $0.5980, inclusive. The Reporting Person undertakes to provide to Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range specified in this footnote.

F5 · ownership.nature: The Reporting Person is the Co-Trustee of the Conlin Family Foundation Trust and in such capacity has the shared right to vote and dispose of the securities held by such trust.

SEC source: 0001437749-24-006874 · rdgdoc.xml · nonDerivative · entry 7

Schulke Ryan · CIK 0001660850 · Director · Chief Strategy Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · The Schulke Inn Family Family Foundation Trust in which the Reporting Peron serves as a Co-Trustee

Disclosed balance after: 529,159

F6 · price: The price listed in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5104 to $0.5203, inclusive. The Reporting Person undertakes to provide Fluent, Inc., any Fluent, Inc. security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.